All Stories

  1. Isolated Glucocorticoid Deficiency: genetic causes and animal models
  2. SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency
  3. Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through Missplicing
  4. Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action
  5. HS6ST1 Insufficiency Causes Self-Limited Delayed Puberty in Contrast With Other GnRH Deficiency Genes
  6. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation
  7. Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation
  8. Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma
  9. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation
  10. Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells
  11. NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice
  12. Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity
  13. In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism
  14. Novel Dominant-Negative GH Receptor Mutations Expands the Spectrum of GHI and IGF-I Deficiency
  15. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome
  16. Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations
  17. IGSF10mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty
  18. Primary Adrenocortical Insufficiency Case Series: Genetic Etiologies More Common than Expected
  19. Genetic characterisation of children with short stature and GH or IGF1 insensitivity by single gene and whole exome sequencing
  20. Dominant negative STAT5B variants in two families with mild GH insensitivity and eczema
  21. Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
  22. RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
  23. Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma - impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis
  24. Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children
  25. Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation
  26. NNTPseudoexon Activation as a Novel Mechanism for Disease in Two Siblings With Familial Glucocorticoid Deficiency
  27. Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency
  28. Molecular Genetics of Inherited Glucocorticoid Deficiency
  29. Varied clinical presentations of six patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc
  30. cDNA analysis reveals NNT pseudoexon activation in two siblings with familial glucocorticoid deficiency
  31. A heterozygous STAT5B variant in a family with short stature and transient hyperprolactinaemia: a possible dominant negative effect
  32. Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD)
  33. Mitochondrial thiol systems are important players in antioxidant defence for the human adrenal cortex
  34. IGFALS Gene Dosage Effects on Serum IGF-I and Glucose Metabolism, Body Composition, Bone Growth in Length and Width, and the Pharmacokinetics of Recombinant Human IGF-I Administration
  35. Oxidative stress and adrenocortical insufficiency
  36. A novel gene affecting the timing of puberty
  37. A Novel Homozygous Mutation of the <b><i>IGFALS</i></b> Gene in a Female Adolescent: Indirect Evidence for a Contributing Role of the Circulating IGF-I Pool in the Pubertal Growth Spurt
  38. Deficiency of ALADIN Impairs Redox Homeostasis in Human Adrenal Cells and Inhibits Steroidogenesis
  39. Genome sequencing reveals mitochondrial thiol systems are essential for antioxidant defence in human adrenal glands
  40. Familial glucocorticoid deficiency: a diagnostic challenge during acute illness
  41. Familial glucocorticoid deficiency: New genes and mechanisms
  42. Familial constitutional delay in growth and puberty is a condition with significant genetic heterogeneity and limited overlap with the timing of puberty in the general population
  43. A mutation in thioredoxin reductase 2 (TXNRD2) is associated with a predominantly adrenal phenotype in humans
  44. ACTH Resistance: Genes and Mechanisms
  45. Adrenocortical Development, Maintenance, and Disease
  46. A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with familial glucocorticoid deficiency
  47. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency
  48. An Atypical Case of Familial Glucocorticoid Deficiency without Pigmentation Caused by Coexistent Homozygous Mutations inMC2R(T152K) andMC1R(R160W)
  49. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans
  50. Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein
  51. Severe Cortisol Deficiency Associated with Reversible Growth Hormone Deficiency in Two Infants: What Is the Link?
  52. Evidence for a Continuum of Genetic, Phenotypic, and Biochemical Abnormalities in Children with Growth Hormone Insensitivity
  53. Effects of melanocortins on adrenal gland physiology
  54. 5.10 Familial glucocorticoid deficiency
  55. 7.2.3 Genetic defects of the human somatotropic axis
  56. Genetic Defects in the Growth Hormone?IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth
  57. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  58. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  59. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  60. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  61. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  62. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  63. d3‐GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults
  64. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
  65. Acid-Labile Subunit Deficiency and Growth Failure: Description of Two Novel Cases
  66. Familial Isolated Primary Pigmented Nodular Adrenocortical Disease Associated with a Novel Low Penetrance <i>PRKAR1A</i> Gene Splice Site Mutation
  67. Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency
  68. Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity
  69. Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency
  70. Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long‐term mineralocorticoid deficiency
  71. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family
  72. The genetics of familial glucocorticoid deficiency
  73. Accessory proteins are vital for the functional expression of certain G protein-coupled receptors
  74. Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations
  75. Phenotypic Aspects of Growth Hormone- and IGF-I-Resistant Syndromes
  76. The Majority of Adrenocorticotropin Receptor (Melanocortin 2 Receptor) Mutations Found in Familial Glucocorticoid Deficiency Type 1 Lead to Defective Trafficking of the Receptor to the Cell Surface
  77. OR9,3 Acid-labile subunit gene mutations: clinical, biochemical and molecular study in two unrelated families
  78. Adrenocorticotropin Resistance Syndromes
  79. Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
  80. Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein
  81. The TPIT Gene Mutation M86R Associated with Isolated Adrenocorticotropin Deficiency Interferes with Protein: Protein Interactions
  82. Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
  83. Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes
  84. An Intronic Growth Hormone Receptor Mutation Causing Activation of a Pseudoexon Is Associated with a Broad Spectrum of Growth Hormone Insensitivity Phenotypes
  85. Growth Hormone Insensitivity and Severe Short Stature in Siblings: A Novel Mutation at the Exon 13-Intron 13 Junction of the <i>STAT5b</i> Gene
  86. The genetics of ACTH resistance syndromes
  87. Severe loss‐of‐function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt‐losing adrenal hypoplasia
  88. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
  89. Mechanisms of Disease: the adrenocorticotropin receptor and disease
  90. A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling
  91. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action
  92. Diagnostic and Therapeutic Advances in Growth Hormone Insensitivity
  93. Genetics of ACTH insensitivity syndromes
  94. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2
  95. Novel Growth Hormone Receptor Mutation in a Chinese Patient with Laron Syndrome
  96. TPIT mutations are associated with early-onset, but not late-onset isolated ACTH deficiency
  97. Growth Hormone (GH) Insensitivity Syndrome due to a GH Receptor Truncated after Box1, Resulting in Isolated Failure of STAT 5 Signal Transduction
  98. Mutations in a Novel Gene, Encoding a Single Transmembrane Domain Protein Are Associated with Familial Glucocorticoid Deficiency Type 2
  99. Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor
  100. Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity
  101. Detection of rpoB Mutations in Mycobacterium tuberculosis by Biprobe Analysis
  102. Pseudoexon Activation as a Novel Mechanism for Disease Resulting in Atypical Growth-Hormone Insensitivity
  103. Growth Hormone Insensitivity: Pathophysiology, Diagnosis, Clinical Variation and Future Perspectives
  104. Tall stature in familial glucocorticoid deficiency
  105. NOSOCOMIAL ACQUISITION OFBURKHOLDERIA GLADIOLIIN PATIENTS WITH CYSTIC FIBROSIS
  106. Predictive modelling of fluorescent AFLP: a new approach to the molecular epidemiology of
  107. Investigation of an outbreak of multidrug resistant tuberculosis among renal patients using rpo B genes sequencing and IS6110 inverse PCR
  108. Rapid, sensitive, microbial detection by gene amplification using restriction endonuclease target sequences
  109. Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods
  110. Utility of Polycation-Treated Filters for the Assay of Receptors for VIP
  111. IGF-I Deficiency: Lessons from Human Mutations